Tuberkulose am Arbeitsplatz, Version 2010

110 Drobniewski F. Tuberculosis in prisons-forgotten plague. Lancet. 1995; 346:
p. 948-949.
111 Glaser JB, Greifinger RB. Correctional health care: a public health opportunity. Ann
Intern Med. 1993; 118: p. 139-145.
112 Nyangulu DS, Harries AD, Kang’ombe C, Yadidi AE, Chokani K, Cullinan T, et al.
Tuberculosis in a prison population in Malawi. Lancet. 1997; 350: p. 1284-1287.
113 Coninx R, Pfyffer GE, Mathieu C, Savina D, Debacker M, Jafarov F, et al. Drug
resistant tuberculosis in prisons in Azerbaijan: case study. BMJ. 1998; 316:
p. 1423-1425.
114 Chevallay B, Haller RD, Bernheim J. Epidemiology of pulmonary tuberculosis in the
prison environment. Schweiz Med Wochenschr. 1983; 113: p. 261-265.
115 Bundesgesetz über den Allgemeinen Teil des Sozialversicherungsrechts (ATSG)
vom 6. Oktober 2000.
116 Pai M, O’Brien R. Serial testing for tuberculosis: can we make sense of T cell assay
conversions and reversions? PLoS Med. 2007; 4: p. e208.
117 Detjen AK, Loebenberg L, Grewal HMS, Stanley K, Gutschmidt A, Kruger C, et al.
Short-term reproducibility of a commercial interferon gamma release assay. Clin
Vaccine Immunol. 2009; 16: p. 1170-1175.
118 Zyl van RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferongamma
assay results for tuberculosis and boosting effect of tuberculin skin testing:
a systematic review. PLoS One. 2009; 4: p. e8517.
119 Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparsion of commercial
Interferon- release assays for detecting active tuberculosis. Chest. 2010; 137: p.
1-17.
77